Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--A multicenter study

Abstract

MMF monotherapy causes a moderate decrease in proteinuria in >50% of the patients who do not have other treatment options. The response to therapy is largely influenced by a preserved renal function and requires sustained MMF treatment.